Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.770 USD | -3.74% |
|
+16.73% | +12.30% |
Feb. 14 | Peloton wins dismissal of shareholder lawsuit over seat post recall | RE |
Feb. 14 | Peloton wins dismissal of shareholder lawsuit over seat post recall | RE |
Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | -0.67 | -2.1 | -22.31 | -13.58 | -10 | |||
Return on Total Capital | -0.97 | -2.86 | -30.47 | -18.33 | -13.66 | |||
Return On Equity % | -6.88 | -11.01 | -240.96 | -847.35 | 135.57 | |||
Return on Common Equity | -12.57 | -11.01 | -240.96 | -847.35 | 135.57 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | 45.82 | 36.1 | 19.49 | 32.98 | 44.71 | |||
SG&A Margin | 42.07 | 33.06 | 51.87 | 47.98 | 48.11 | |||
EBITDA Margin % | 0.71 | -1.75 | -39.09 | -23.3 | -12.24 | |||
EBITA Margin % | -0.84 | -2.64 | -41.21 | -25.8 | -14.29 | |||
EBIT Margin % | -1.12 | -3.12 | -42.42 | -26.36 | -14.68 | |||
Income From Continuing Operations Margin % | -3.92 | -4.7 | -78.94 | -45.06 | -20.44 | |||
Net Income Margin % | -3.92 | -4.7 | -78.94 | -45.06 | -20.44 | |||
Net Avail. For Common Margin % | -3.92 | -4.7 | -78.94 | -45.06 | -20.44 | |||
Normalized Net Income Margin | -0.27 | -2.11 | -27.8 | -17.84 | -10.95 | |||
Levered Free Cash Flow Margin | 11.37 | -12.66 | -32.45 | 5.45 | 10.49 | |||
Unlevered Free Cash Flow Margin | 11.37 | -12.75 | -32.68 | 7.13 | 12.56 | |||
Asset Turnover | ||||||||
Asset Turnover | 0.95 | 1.08 | 0.84 | 0.82 | 1.09 | |||
Fixed Assets Turnover | 3.71 | 4.22 | 2.93 | 2.5 | 3.07 | |||
Receivables Turnover (Average Receivables) | 68.77 | 75.88 | 46.22 | 30.98 | 26.9 | |||
Inventory Turnover (Average Inventory) | 5.19 | 4.35 | 2.83 | 2.31 | 3.5 | |||
Short Term Liquidity | ||||||||
Current Ratio | 2.8 | 2.27 | 2.38 | 2.15 | 1.85 | |||
Quick Ratio | 2.32 | 1.35 | 1.21 | 1.2 | 1.17 | |||
Operating Cash Flow to Current Liabilities | 0.49 | -0.19 | -1.83 | -0.51 | -0.1 | |||
Days Sales Outstanding (Average Receivables) | 5.32 | 4.81 | 7.9 | 11.78 | 13.61 | |||
Days Outstanding Inventory (Average Inventory) | 70.5 | 83.91 | 129.2 | 158.23 | 104.47 | |||
Average Days Payable Outstanding | 38.03 | 27.98 | 27.36 | 23.89 | 22.79 | |||
Cash Conversion Cycle (Average Days) | 37.79 | 60.74 | 109.74 | 146.12 | 95.29 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | 32.49 | 86.2 | 400.29 | -800.98 | -400.46 | |||
Total Debt / Total Capital | 24.52 | 46.3 | 80.01 | 114.27 | 133.28 | |||
LT Debt/Equity | 30.29 | 82.67 | 384.45 | -770.15 | -384.03 | |||
Long-Term Debt / Total Capital | 22.86 | 44.4 | 76.85 | 109.87 | 127.81 | |||
Total Liabilities / Total Assets | 43.73 | 60.89 | 85.28 | 110.66 | 123.76 | |||
EBIT / Interest Expense | - | -8.48 | -35.33 | -7.6 | -3.52 | |||
EBITDA / Interest Expense | - | 3.51 | -28.67 | -5.48 | -2.04 | |||
(EBITDA - Capex) / Interest Expense | - | -12.77 | -36.88 | -6.33 | -2.22 | |||
Total Debt / EBITDA | 5.3 | 29.08 | -1.93 | -4.44 | -9.05 | |||
Net Debt / EBITDA | -11.77 | -1.82 | -0.91 | -2.91 | -6.01 | |||
Total Debt / (EBITDA - Capex) | -10.17 | -8 | -1.5 | -3.85 | -8.34 | |||
Net Debt / (EBITDA - Capex) | 22.57 | 0.5 | -0.71 | -2.52 | -5.54 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | 99.55 | 120.27 | -10.93 | -21.83 | -3.57 | |||
Gross Profit, 1 Yr. Growth % | 118.17 | 73.55 | -51.99 | 32.25 | 30.21 | |||
EBITDA, 1 Yr. Growth % | -107.51 | -621.48 | 2.1K | -53.58 | -49.05 | |||
EBITA, 1 Yr. Growth % | -91.68 | 618.24 | 1.39K | -51.23 | -46.31 | |||
EBIT, 1 Yr. Growth % | -89.22 | 530.65 | 1.18K | -51.58 | -46.03 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | -63.39 | 163.97 | 1.4K | -55.38 | -56.26 | |||
Net Income, 1 Yr. Growth % |